Silhouette Mid-face
Suture™ Receives TGA Approval in Australia
For Immediate Release: May 7, 2007
(Corona), California – Kolster
Methods, Inc., the inventor and developer of
the semi-bioabsorbable Silhouette Mid-face
Suture™ for the fixation of soft tissue in
the aesthetic and plastic and reconstructive
surgery markets, announced today that it has
received Australian TGA approval for the
Silhouette Mid-face Suture™device. The
Silhouette Mid-face Suture™device received
FDA clearance in October 2006, CE Marking in
January of 2007, and is pending approval in
Korea and a host of other countries. The
device will be exclusively distributed in
Australia by Austramedex. Austramedex is the
leading Australian company for the marketing
and distribution of many aesthetic surgery
products.This
product is the very first in a series of
Silhouette suture products with various
“indications for use” that we plan to
introduce over the next twelve months that
will enable us to continue to meet the needs
of our surgeon customers in the plastic
surgery market. Current trials are underway
that are designed to determine the use and
effectiveness of the device in the brow,
breast and abdomen of patients
and also separate studies are being
conducted for wound closure
applications.
About Kolster Methods,
Inc. (K.M.I.)
Kolster Methods, Inc., develops,
manufactures and markets a range of
aesthetic and plastic and reconstructive
surgery products for liposuction, endoscopic
and laparoscopic surgery. Located in Corona,
California, Kolster Methods Inc. is a
privately held company.
For more
information contact K.M.I. at 951-737-5476.
|